Response criteria for intraocular retinoblastoma: RB-RECIST.

Détails

ID Serval
serval:BIB_70FCDED2D144
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Response criteria for intraocular retinoblastoma: RB-RECIST.
Périodique
Pediatric blood & cancer
Auteur(s)
Berry J.L., Munier F.L., Gallie B.L., Polski A., Shah S., Shields C.L., Gombos D.S., Ruchalski K., Stathopoulos C., Shah R., Jubran R., Kim J.W., Mruthyunjaya P., Marr B.P., Wilson M.W., Brennan R.C., Chantada G.L., Chintagumpala M.M., Murphree A.L.
ISSN
1545-5017 (Electronic)
ISSN-L
1545-5009
Statut éditorial
Publié
Date de publication
05/2021
Peer-reviewed
Oui
Volume
68
Numéro
5
Pages
e28964
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Standardized guidelines for assessing tumor response to therapy are essential for designing and conducting clinical trials. The Response Evaluation Criteria In Solid Tumors (RECIST) provide radiological standards for assessment of solid tumors. However, no such guidelines exist for the evaluation of intraocular cancer, and ocular oncology clinical trials have largely relied on indirect measures of therapeutic response-such as progression-free survival-to evaluate the efficacy of treatment agents. Herein, we propose specific criteria for evaluating treatment response of retinoblastoma, the most common pediatric intraocular cancer, and emphasize a multimodal imaging approach for comprehensive assessment of retinoblastoma tumors in clinical trials.
Mots-clé
clinical trials, imaging, ocular oncology, response criteria, retinoblastoma, ultrasonography
Pubmed
Web of science
Open Access
Oui
Création de la notice
01/03/2021 12:20
Dernière modification de la notice
18/06/2021 6:36
Données d'usage